Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000080

Chief Scientific Officer sold 4,196 shares at $6.50 ($27,274)

  • Chief Scientific Officer acquired 4,196 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-07-29 Option exercise 10b5-1 +4,196 $0.06 $252 4,196 D: show line 1 in the form
Moreadith Randall Chief Scientific Officer 2025-07-29 Sale 10b5-1 −4,196 $6.50 $27,274 0 D: show line 2 in the form
Open-market sales · 4,196 sh · avg $6.50 · $27,274

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-07-29 Option exercise · Stock Option (right to buy) 10b5-1 −4,196 484,490 D: show line 3 in the form
Loading xslF345X05/wk-form4_1753897670.xml…